Home > Financial, General > Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Medivation, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 10, 2010 Lead Plaintiff Deadline

Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Medivation, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 10, 2010 Lead Plaintiff Deadline

March 12th, 2010

STEVENSON, MD–(Marketwire – Mar 12, 2010) –  Brower Piven, A Professional Corporation announces which a category movement legal case has been commenced in the United States District Court for the Northern District of California on interest of purchasers of the usual batch of Medivation, Inc. (“Medivation” or the “Company”) (NASDAQ: MDVN) during the duration in between Jul 17, 2008 and Mar 2, 2010, thorough (the “Class Period”).
No category has nonetheless been approved in the on top of action. Members of the Class will be represented by the lead plaintiff and warn comparison by the lead plaintiff. If you instruct to select warn to paint you and the Class, you contingency request to be allocated lead plaintiff no after than May 10, 2010 and be comparison by the Court. The lead plaintiff will approach the legal case and knowledge in critical decisions together with either to accept a allotment and how most of a allotment to accept for the Class in the action. The lead plaintiff will be comparison from between field claiming the largest detriment from investment in the Company during the Class Period. You have been not compulsory to have sole your shares to find indemnification or to offer as a Lead Plaintiff. You might hit Brower Piven (through hoffman@browerpiven.com or 410/415-6616) to answer any questions you might have in which regard. 
The censure accuses the defendants of violations of the Securities Exchange Act of 1934 by trait of the Company’s distribution during the Class Period of fake and dubious statements to the investing open about the efficacy of Dimebon as a diagnosis for Alzheimer’s disease, to illustrate creation it unfit for investors to entirely bargain the drug’s prospects for FDA capitulation and destiny blurb viability. 
If you have suffered a net detriment for all exchange in Medivation, Inc. usual batch during the Class Period, you might acquire one more report about this legal case and your capability to turn a lead plaintiff by contacting Brower Piven at www.browerpiven.com, by email at hoffman@browerpiven.com, by job 410/415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have total knowledge litigating bonds and category movement cases of over 40 years. If you select to keep counsel, you might keep Brower Piven but monetary requisite or price to you, or you might keep alternative warn of your choice. You need take no movement at this time to be a part of of the class.

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • BarraPunto
  • Bitacoras.com
  • BlinkList

admin Financial, General , ,

  1. No comments yet.
  1. No trackbacks yet.